Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid ?over-treatment? of the cancer patients.
This report aims to provide a comprehensive presentation of the global market for Cancer Tumor Profiling, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Tumor Profiling. This report contains market size and forecasts of Cancer Tumor Profiling in global, including the following market information:
Global Cancer Tumor Profiling Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Tumor Profiling market was valued at US$ 40550 million in 2022 and is projected to reach US$ 78790 million by 2030, at a CAGR of 10.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
We surveyed the Cancer Tumor Profiling companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Tumor Profiling Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cancer Tumor Profiling Market Segment Percentages, by Type, 2022 (%)
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Global Cancer Tumor Profiling Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cancer Tumor Profiling Market Segment Percentages, by Application, 2022 (%)
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Global Cancer Tumor Profiling Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cancer Tumor Profiling Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Tumor Profiling revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Tumor Profiling revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Tumor Profiling, market overview.
Chapter 2: Global Cancer Tumor Profiling market size in revenue.
Chapter 3: Detailed analysis of Cancer Tumor Profiling company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Tumor Profiling in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Tumor Profiling Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Tumor Profiling Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Tumor Profiling Overall Market Size
2.1 Global Cancer Tumor Profiling Market Size: 2022 VS 2030
2.2 Global Cancer Tumor Profiling Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Tumor Profiling Players in Global Market
3.2 Top Global Cancer Tumor Profiling Companies Ranked by Revenue
3.3 Global Cancer Tumor Profiling Revenue by Companies
3.4 Top 3 and Top 5 Cancer Tumor Profiling Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Tumor Profiling Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Tumor Profiling Players in Global Market
3.6.1 List of Global Tier 1 Cancer Tumor Profiling Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Tumor Profiling Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Tumor Profiling Market Size Markets, 2022 & 2030
4.1.2 Next-generation Sequencing (NGS)
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Immunohistochemistry (IHC)
4.1.5 In Situ Hybridization (ISH)
4.1.6 Microarray
4.1.7 Others
4.2 By Type - Global Cancer Tumor Profiling Revenue & Forecasts
4.2.1 By Type - Global Cancer Tumor Profiling Revenue, 2018-2023
4.2.2 By Type - Global Cancer Tumor Profiling Revenue, 2024-2030
4.2.3 By Type - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Tumor Profiling Market Size, 2022 & 2030
5.1.2 Personalized Medicine
5.1.3 Diagnostics
5.1.4 Biomarker Discovery
5.1.5 Prognostics
5.1.6 Research Applications
5.2 By Application - Global Cancer Tumor Profiling Revenue & Forecasts
5.2.1 By Application - Global Cancer Tumor Profiling Revenue, 2018-2023
5.2.2 By Application - Global Cancer Tumor Profiling Revenue, 2024-2030
5.2.3 By Application - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Tumor Profiling Market Size, 2022 & 2030
6.2 By Region - Global Cancer Tumor Profiling Revenue & Forecasts
6.2.1 By Region - Global Cancer Tumor Profiling Revenue, 2018-2023
6.2.2 By Region - Global Cancer Tumor Profiling Revenue, 2024-2030
6.2.3 By Region - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Tumor Profiling Revenue, 2018-2030
6.3.2 US Cancer Tumor Profiling Market Size, 2018-2030
6.3.3 Canada Cancer Tumor Profiling Market Size, 2018-2030
6.3.4 Mexico Cancer Tumor Profiling Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Tumor Profiling Revenue, 2018-2030
6.4.2 Germany Cancer Tumor Profiling Market Size, 2018-2030
6.4.3 France Cancer Tumor Profiling Market Size, 2018-2030
6.4.4 U.K. Cancer Tumor Profiling Market Size, 2018-2030
6.4.5 Italy Cancer Tumor Profiling Market Size, 2018-2030
6.4.6 Russia Cancer Tumor Profiling Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Tumor Profiling Market Size, 2018-2030
6.4.8 Benelux Cancer Tumor Profiling Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Tumor Profiling Revenue, 2018-2030
6.5.2 China Cancer Tumor Profiling Market Size, 2018-2030
6.5.3 Japan Cancer Tumor Profiling Market Size, 2018-2030
6.5.4 South Korea Cancer Tumor Profiling Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Tumor Profiling Market Size, 2018-2030
6.5.6 India Cancer Tumor Profiling Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Tumor Profiling Revenue, 2018-2030
6.6.2 Brazil Cancer Tumor Profiling Market Size, 2018-2030
6.6.3 Argentina Cancer Tumor Profiling Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Tumor Profiling Revenue, 2018-2030
6.7.2 Turkey Cancer Tumor Profiling Market Size, 2018-2030
6.7.3 Israel Cancer Tumor Profiling Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Tumor Profiling Market Size, 2018-2030
6.7.5 UAE Cancer Tumor Profiling Market Size, 2018-2030
7 Cancer Tumor Profiling Companies Profiles
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Company Summary
7.1.2 Qiagen N.V. Business Overview
7.1.3 Qiagen N.V. Cancer Tumor Profiling Major Product Offerings
7.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.1.5 Qiagen N.V. Key News & Latest Developments
7.2 Roche Molecular Systems Inc.
7.2.1 Roche Molecular Systems Inc. Company Summary
7.2.2 Roche Molecular Systems Inc. Business Overview
7.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Major Product Offerings
7.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.2.5 Roche Molecular Systems Inc. Key News & Latest Developments
7.3 Abott Molecular
7.3.1 Abott Molecular Company Summary
7.3.2 Abott Molecular Business Overview
7.3.3 Abott Molecular Cancer Tumor Profiling Major Product Offerings
7.3.4 Abott Molecular Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.3.5 Abott Molecular Key News & Latest Developments
7.4 Illumina Inc.
7.4.1 Illumina Inc. Company Summary
7.4.2 Illumina Inc. Business Overview
7.4.3 Illumina Inc. Cancer Tumor Profiling Major Product Offerings
7.4.4 Illumina Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.4.5 Illumina Inc. Key News & Latest Developments
7.5 NeoGenomics Laboratories
7.5.1 NeoGenomics Laboratories Company Summary
7.5.2 NeoGenomics Laboratories Business Overview
7.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Major Product Offerings
7.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.5.5 NeoGenomics Laboratories Key News & Latest Developments
7.6 HTG Molecular Diagnostic
7.6.1 HTG Molecular Diagnostic Company Summary
7.6.2 HTG Molecular Diagnostic Business Overview
7.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Major Product Offerings
7.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.6.5 HTG Molecular Diagnostic Key News & Latest Developments
7.7 Genomic Health Inc.
7.7.1 Genomic Health Inc. Company Summary
7.7.2 Genomic Health Inc. Business Overview
7.7.3 Genomic Health Inc. Cancer Tumor Profiling Major Product Offerings
7.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.7.5 Genomic Health Inc. Key News & Latest Developments
7.8 Hologic Gen-Probe
7.8.1 Hologic Gen-Probe Company Summary
7.8.2 Hologic Gen-Probe Business Overview
7.8.3 Hologic Gen-Probe Cancer Tumor Profiling Major Product Offerings
7.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.8.5 Hologic Gen-Probe Key News & Latest Developments
7.9 BD Biosciences
7.9.1 BD Biosciences Company Summary
7.9.2 BD Biosciences Business Overview
7.9.3 BD Biosciences Cancer Tumor Profiling Major Product Offerings
7.9.4 BD Biosciences Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.9.5 BD Biosciences Key News & Latest Developments
7.10 Siemens Healthineers
7.10.1 Siemens Healthineers Company Summary
7.10.2 Siemens Healthineers Business Overview
7.10.3 Siemens Healthineers Cancer Tumor Profiling Major Product Offerings
7.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.10.5 Siemens Healthineers Key News & Latest Developments
7.11 Claris Life Sciences
7.11.1 Claris Life Sciences Company Summary
7.11.2 Claris Life Sciences Business Overview
7.11.3 Claris Life Sciences Cancer Tumor Profiling Major Product Offerings
7.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.11.5 Claris Life Sciences Key News & Latest Developments
7.12 Personal Genome Diagnostics, Inc.
7.12.1 Personal Genome Diagnostics, Inc. Company Summary
7.12.2 Personal Genome Diagnostics, Inc. Business Overview
7.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Major Product Offerings
7.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.12.5 Personal Genome Diagnostics, Inc. Key News & Latest Developments
7.13 Perthera, Inc.
7.13.1 Perthera, Inc. Company Summary
7.13.2 Perthera, Inc. Business Overview
7.13.3 Perthera, Inc. Cancer Tumor Profiling Major Product Offerings
7.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.13.5 Perthera, Inc. Key News & Latest Developments
7.14 Foundation Medicine, Inc
7.14.1 Foundation Medicine, Inc Company Summary
7.14.2 Foundation Medicine, Inc Business Overview
7.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Major Product Offerings
7.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.14.5 Foundation Medicine, Inc Key News & Latest Developments
7.15 V., Strand
7.15.1 V., Strand Company Summary
7.15.2 V., Strand Business Overview
7.15.3 V., Strand Cancer Tumor Profiling Major Product Offerings
7.15.4 V., Strand Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.15.5 V., Strand Key News & Latest Developments
7.16 ApoCell
7.16.1 ApoCell Company Summary
7.16.2 ApoCell Business Overview
7.16.3 ApoCell Cancer Tumor Profiling Major Product Offerings
7.16.4 ApoCell Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.16.5 ApoCell Key News & Latest Developments
7.17 Contextual Genomics
7.17.1 Contextual Genomics Company Summary
7.17.2 Contextual Genomics Business Overview
7.17.3 Contextual Genomics Cancer Tumor Profiling Major Product Offerings
7.17.4 Contextual Genomics Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.17.5 Contextual Genomics Key News & Latest Developments
7.18 Agendia
7.18.1 Agendia Company Summary
7.18.2 Agendia Business Overview
7.18.3 Agendia Cancer Tumor Profiling Major Product Offerings
7.18.4 Agendia Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.18.5 Agendia Key News & Latest Developments
7.19 GenScript
7.19.1 GenScript Company Summary
7.19.2 GenScript Business Overview
7.19.3 GenScript Cancer Tumor Profiling Major Product Offerings
7.19.4 GenScript Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.19.5 GenScript Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Tumor Profiling Market Opportunities & Trends in Global Market
Table 2. Cancer Tumor Profiling Market Drivers in Global Market
Table 3. Cancer Tumor Profiling Market Restraints in Global Market
Table 4. Key Players of Cancer Tumor Profiling in Global Market
Table 5. Top Cancer Tumor Profiling Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Tumor Profiling Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Tumor Profiling Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Tumor Profiling Product Type
Table 9. List of Global Tier 1 Cancer Tumor Profiling Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Tumor Profiling Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Tumor Profiling Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cancer Tumor Profiling Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cancer Tumor Profiling Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cancer Tumor Profiling Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Tumor Profiling Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Tumor Profiling Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Tumor Profiling Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Tumor Profiling Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Tumor Profiling Revenue, (US$, Mn), 2024-2030
Table 30. Qiagen N.V. Company Summary
Table 31. Qiagen N.V. Cancer Tumor Profiling Product Offerings
Table 32. Qiagen N.V. Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 33. Qiagen N.V. Key News & Latest Developments
Table 34. Roche Molecular Systems Inc. Company Summary
Table 35. Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offerings
Table 36. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Molecular Systems Inc. Key News & Latest Developments
Table 38. Abott Molecular Company Summary
Table 39. Abott Molecular Cancer Tumor Profiling Product Offerings
Table 40. Abott Molecular Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 41. Abott Molecular Key News & Latest Developments
Table 42. Illumina Inc. Company Summary
Table 43. Illumina Inc. Cancer Tumor Profiling Product Offerings
Table 44. Illumina Inc. Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 45. Illumina Inc. Key News & Latest Developments
Table 46. NeoGenomics Laboratories Company Summary
Table 47. NeoGenomics Laboratories Cancer Tumor Profiling Product Offerings
Table 48. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 49. NeoGenomics Laboratories Key News & Latest Developments
Table 50. HTG Molecular Diagnostic Company Summary
Table 51. HTG Molecular Diagnostic Cancer Tumor Profiling Product Offerings
Table 52. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 53. HTG Molecular Diagnostic Key News & Latest Developments
Table 54. Genomic Health Inc. Company Summary
Table 55. Genomic Health Inc. Cancer Tumor Profiling Product Offerings
Table 56. Genomic Health Inc. Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 57. Genomic Health Inc. Key News & Latest Developments
Table 58. Hologic Gen-Probe Company Summary
Table 59. Hologic Gen-Probe Cancer Tumor Profiling Product Offerings
Table 60. Hologic Gen-Probe Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 61. Hologic Gen-Probe Key News & Latest Developments
Table 62. BD Biosciences Company Summary
Table 63. BD Biosciences Cancer Tumor Profiling Product Offerings
Table 64. BD Biosciences Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 65. BD Biosciences Key News & Latest Developments
Table 66. Siemens Healthineers Company Summary
Table 67. Siemens Healthineers Cancer Tumor Profiling Product Offerings
Table 68. Siemens Healthineers Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 69. Siemens Healthineers Key News & Latest Developments
Table 70. Claris Life Sciences Company Summary
Table 71. Claris Life Sciences Cancer Tumor Profiling Product Offerings
Table 72. Claris Life Sciences Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 73. Claris Life Sciences Key News & Latest Developments
Table 74. Personal Genome Diagnostics, Inc. Company Summary
Table 75. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offerings
Table 76. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 77. Personal Genome Diagnostics, Inc. Key News & Latest Developments
Table 78. Perthera, Inc. Company Summary
Table 79. Perthera, Inc. Cancer Tumor Profiling Product Offerings
Table 80. Perthera, Inc. Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 81. Perthera, Inc. Key News & Latest Developments
Table 82. Foundation Medicine, Inc Company Summary
Table 83. Foundation Medicine, Inc Cancer Tumor Profiling Product Offerings
Table 84. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 85. Foundation Medicine, Inc Key News & Latest Developments
Table 86. V., Strand Company Summary
Table 87. V., Strand Cancer Tumor Profiling Product Offerings
Table 88. V., Strand Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 89. V., Strand Key News & Latest Developments
Table 90. ApoCell Company Summary
Table 91. ApoCell Cancer Tumor Profiling Product Offerings
Table 92. ApoCell Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 93. ApoCell Key News & Latest Developments
Table 94. Contextual Genomics Company Summary
Table 95. Contextual Genomics Cancer Tumor Profiling Product Offerings
Table 96. Contextual Genomics Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 97. Contextual Genomics Key News & Latest Developments
Table 98. Agendia Company Summary
Table 99. Agendia Cancer Tumor Profiling Product Offerings
Table 100. Agendia Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 101. Agendia Key News & Latest Developments
Table 102. GenScript Company Summary
Table 103. GenScript Cancer Tumor Profiling Product Offerings
Table 104. GenScript Cancer Tumor Profiling Revenue (US$, Mn) & (2018-2023)
Table 105. GenScript Key News & Latest Developments
List of Figures
Figure 1. Cancer Tumor Profiling Segment by Type in 2022
Figure 2. Cancer Tumor Profiling Segment by Application in 2022
Figure 3. Global Cancer Tumor Profiling Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Tumor Profiling Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cancer Tumor Profiling Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2022
Figure 8. By Type - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cancer Tumor Profiling Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cancer Tumor Profiling Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 16. US Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 20. Germany Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 21. France Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 28. China Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 32. India Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 34. Brazil Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cancer Tumor Profiling Revenue Market Share, 2018-2030
Figure 37. Turkey Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cancer Tumor Profiling Revenue, (US$, Mn), 2018-2030
Figure 41. Qiagen N.V. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abott Molecular Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Illumina Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. NeoGenomics Laboratories Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genomic Health Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hologic Gen-Probe Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. BD Biosciences Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Siemens Healthineers Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Claris Life Sciences Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Perthera, Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Foundation Medicine, Inc Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. V., Strand Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. ApoCell Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Contextual Genomics Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Agendia Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. GenScript Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
